Safety and efficacy of buparlisib (BKM120) and chemotherapy in advanced, squamous non-small cell lung cancer (sqNSCLC): Results from the phase Ib/II BASALT-2 and BASALT-3 studies.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e20522-e20522 ◽  
Author(s):  
Alex A. Adjei ◽  
Jaafar Bennouna ◽  
Natasha B. Leighl ◽  
Enriqueta Felip ◽  
Diego Luigi Cortinovis ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Safety And Efficacy ◽  
Phase Ib

scholarly journals Five‐year safety and efficacy data from a phase Ib study of nivolumab and chemotherapy in advanced non‐small‐cell lung cancer

2020 ◽  
Vol 111 (6) ◽  
pp. 1933-1942
Author(s):  
Shintaro Kanda ◽  
Yuichiro Ohe ◽  
Yasushi Goto ◽  
Hidehito Horinouchi ◽  
Yutaka Fujiwara ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Efficacy Data ◽  
Safety And Efficacy ◽  
Phase Ib

scholarly journals Safety and efficacy of carboplatin plus nab-paclitaxel for treating advanced non-small-cell lung cancer with interstitial lung disease

2017 ◽  
Vol 7 (4) ◽  
pp. 604-608 ◽  
Author(s):  
Hideyuki Niwa ◽  
Yoshiro Nakahara ◽  
Masanori Yokoba ◽  
Hisashi Mitsufuji ◽  
Jiichiro Sasaki ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Interstitial Lung Disease ◽  
Small Cell Lung Cancer ◽  
Lung Disease ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Safety And Efficacy
Sign in / Sign up

Export Citation Format

Share Document